Menactra Injection, Solution
Product Images NDC 49281-589

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Menactra (NDC 49281-589). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sanofi Vaccines Us Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (0.5 mL Vial Label)

This is a description of Menactra® vaccine, a meningococcal conjugate vaccine manufactured by Sanofi Pasteur Inc. The vaccine provides protection against meningococcal infections caused by groups A, C, Y, and W-135. The NDC code for the vaccine is 49281-589-58, and it is available in a single-dose form. The vaccine contains Diphtheria Toxoid Polysaccharide along with the meningococcal conjugate vaccine. The text appears to be missing some vital information, such as dosage and administration details.*

FDA Label Image

Principal Display Panel (5 Vial Package)

This is a description of a vaccine called Menactra, which is used to protect against Meningococcal disease caused by bacteria groups A, C, Y, and W-135. The vaccine is administered intramuscularly with a dosage of 0.5 mL per dose containing 4 meg of each polysaccharide per serogroup. The vaccine should not be frozen and should be stored at 2°C to 8°C. The vaccine is manufactured by Sanofi Pasteur Inc. and has no preservatives. Menactra is intended for people aged 9 months through 55 years.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.